eye+or+ocular	11102475	7124	Tezel G	Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells.	The Journal of neuroscience 	2000	92
eye+or+ocular	17589522	7124	Connor KM	Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.	Nature medicine	2007	189
eye+or+ocular	18029267	7124	Gupta V	Intraocular tuberculosis--an update.	Survey of ophthalmology	2007	79
eye+or+ocular	20664046	7124	Ramos-Casals M	Treatment of primary Sjögren syndrome: a systematic review.	JAMA	2010	46
eye+or+ocular	21252670	7124	Danesh-Meyer HV	Neuroprotection in glaucoma: recent and future directions.	Current opinion in ophthalmology	2011	37
eye+or+ocular	21917936	7124	Yang X	Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina.	Investigative ophthalmology and visual science	2011	37
eye+or+ocular	26154136	7124	Vavricka SR	Extraintestinal Manifestations of Inflammatory Bowel Disease.	Inflammatory bowel diseases	2015	16
food+or+nutrition+or+nutrients	11596589	7124	Keane J	Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.	The New England journal of medicine	2001	504
food+or+nutrition+or+nutrients	11762947	7124	Mohan N	Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.	Arthritis and rheumatism	2001	96
food+or+nutrition+or+nutrients	14988838	7124	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	127
food+or+nutrition+or+nutrients	15127338	7124	Wallis RS	Granulomatous infectious diseases associated with tumor necrosis factor antagonists.	Clinical infectious diseases 	2004	122
food+or+nutrition+or+nutrients	16439435	7124	Schiff MH	Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.	Annals of the rheumatic diseases	2006	60
food+or+nutrition+or+nutrients	17093155	7124	Weiss EP	Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial.	The American journal of clinical nutrition	2006	106
food+or+nutrition+or+nutrients	17255842	7124	Mackey AC	Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.	Journal of pediatric gastroenterology and nutrition	2007	62
food+or+nutrition+or+nutrients	17589522	7124	Connor KM	Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.	Nature medicine	2007	189
food+or+nutrition+or+nutrients	19210794	7124	Jones SE	Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.	BMC microbiology	2009	56
food+or+nutrition+or+nutrients	20888436	7124	Kotlyar DS	A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.	Clinical gastroenterology and hepatology 	2011	46
food+or+nutrition+or+nutrients	23425071	7124	Aggarwal BB	Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.	British journal of pharmacology	2013	36
food+or+nutrition+or+nutrients	24388027	7124	Leise MD	Drug-induced liver injury.	Mayo Clinic proceedings	2014	41
food+or+nutrition+or+nutrients	26187233	7124	Ravussin E	A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	37
food+or+nutrition+or+nutrients	26468751	7124	Lewis JD	Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.	Cell host and microbe	2015	34
food+or+nutrition+or+nutrients	26582965	7124	Michielan A	Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.	Mediators of inflammation	2015	22
glycoproteins	2158863	7124	Schall TJ	Molecular cloning and expression of a receptor for human tumor necrosis factor.	Cell	1990	149
glycoproteins	2657427	7124	Grau GE	Tumor necrosis factor and disease severity in children with falciparum malaria.	The New England journal of medicine	1989	211
glycoproteins	2762307	7124	Duh EJ	Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.	Proceedings of the National Academy of Sciences of the United States of America	1989	228
glycoproteins	2880163	7124	Waage A	Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.	Lancet	1987	172
glycoproteins	7797011	7124	van Dullemen HM	Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).	Gastroenterology	1995	134
glycoproteins	7935762	7124	McGuire W	Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.	Nature	1994	149
glycoproteins	8015728	7124	Mogi M	Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.	Neuroscience letters	1994	133
glycoproteins	8198398	7124	Tracey KJ	Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.	Annual review of medicine	1994	148
glycoproteins	9321530	7124	Targan SR	A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.	The New England journal of medicine	1997	358
glycoproteins	9435233	7124	Grell M	The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.	Proceedings of the National Academy of Sciences of the United States of America	1998	101
glycoproteins	9725266	7124	Balcewicz-Sablinska MK	Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.	Journal of immunology	1998	106
glycoproteins	10449104	7124	-	TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.	Neurology	1999	134
glycoproteins	10604883	7124	Ouchi N	Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.	Circulation	1999	304
glycoproteins	10622295	7124	Maini R	Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.	Lancet	1999	332
glycoproteins	10801754	7124	Ridker PM	Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.	Circulation	2000	139
glycoproteins	11096166	7124	Lipsky PE	Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.	The New England journal of medicine	2000	455
glycoproteins	11156641	7124	Wigg AJ	The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.	Gut	2001	123
glycoproteins	11596589	7124	Keane J	Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.	The New England journal of medicine	2001	504
glycoproteins	11732005	7124	Crespo J	Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.	Hepatology	2001	115
glycoproteins	11762947	7124	Mohan N	Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.	Arthritis and rheumatism	2001	96
glycoproteins	11792859	7124	Angelini G	Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.	Proceedings of the National Academy of Sciences of the United States of America	2002	83
glycoproteins	11828008	7124	Piccioli D	Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.	The Journal of experimental medicine	2002	146
glycoproteins	11907116	7124	Belge KU	The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.	Journal of immunology	2002	167
glycoproteins	11961039	7124	Scallon B	Binding and functional comparisons of two types of tumor necrosis factor antagonists.	The Journal of pharmacology and experimental therapeutics	2002	95
glycoproteins	12086951	7124	Kirwan JP	TNF-alpha is a predictor of insulin resistance in human pregnancy.	Diabetes	2002	91
glycoproteins	12493553	7124	Panossian LA	Telomere shortening in T cells correlates with Alzheimer's disease status.	Neurobiology of aging	2003	94
glycoproteins	12528101	7124	Weinblatt ME	Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.	Arthritis and rheumatism	2003	249
glycoproteins	12584368	7124	Baert F	Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.	The New England journal of medicine	2003	224
glycoproteins	12672326	7124	Baughman RP	Sarcoidosis.	Lancet	2003	76
glycoproteins	12799470	7124	Borisy AA	Systematic discovery of multicomponent therapeutics.	Proceedings of the National Academy of Sciences of the United States of America	2003	140
glycoproteins	12829646	7124	Kern PA	Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.	Diabetes	2003	143
glycoproteins	12905464	7124	Gómez-Reino JJ	Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.	Arthritis and rheumatism	2003	128
glycoproteins	12949498	7124	Aggarwal BB	Signalling pathways of the TNF superfamily: a double-edged sword.	Nature reviews. Immunology	2003	502
glycoproteins	14555214	7124	Gaur U	Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.	Biochemical pharmacology	2003	101
glycoproteins	14719195	7124	Furst DE	Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).	The Journal of rheumatology	2003	78
glycoproteins	14988838	7124	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	127
glycoproteins	15044327	7124	Hagemann T	Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.	Carcinogenesis	2004	92
glycoproteins	15127338	7124	Wallis RS	Granulomatous infectious diseases associated with tumor necrosis factor antagonists.	Clinical infectious diseases 	2004	122
glycoproteins	15146409	7124	Keystone EC	Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.	Arthritis and rheumatism	2004	209
glycoproteins	15208584	7124	Wright RJ	Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy.	The Journal of allergy and clinical immunology	2004	71
glycoproteins	15383371	7124	Tchkonia T	Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.	American journal of physiology. Endocrinology and metabolism	2005	67
glycoproteins	15383597	7124	Levy O	Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.	Journal of immunology	2004	99
glycoproteins	15613320	7124	Yonezawa A	Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.	Journal of virology	2005	70
glycoproteins	15626980	7124	Weiler C	Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls.	Spine	2005	82
glycoproteins	15641080	7124	Kobayashi M	Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.	Arthritis and rheumatism	2005	89
glycoproteins	15728381	7124	Palucka AK	Cross-regulation of TNF and IFN-alpha in autoimmune diseases.	Proceedings of the National Academy of Sciences of the United States of America	2005	99
glycoproteins	16151404	7124	Hoogenboom HR	Selecting and screening recombinant antibody libraries.	Nature biotechnology	2005	185
glycoproteins	16162882	7124	Genovese MC	Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.	The New England journal of medicine	2005	212
glycoproteins	16200601	7124	Mease PJ	Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.	Arthritis and rheumatism	2005	96
glycoproteins	16226614	7124	Reich K	Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.	Lancet	2005	102
glycoproteins	16439435	7124	Schiff MH	Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.	Annals of the rheumatic diseases	2006	60
glycoproteins	16447241	7124	Wolfe F	Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.	Arthritis and rheumatism	2006	60
glycoproteins	16472588	7124	Hanauer SB	Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.	Gastroenterology	2006	192
glycoproteins	16481637	7124	Berry MA	Evidence of a role of tumor necrosis factor alpha in refractory asthma.	The New England journal of medicine	2006	150
glycoproteins	16573591	7124	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	96
glycoproteins	16705046	7124	Hyrich KL	Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.	Rheumatology	2006	103
glycoproteins	16705109	7124	Bongartz T	Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.	JAMA	2006	366
glycoproteins	16798876	7124	Yang H	TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
glycoproteins	16802350	7124	van der Heijde D	Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.	Arthritis and rheumatism	2006	102
glycoproteins	16804108	7124	Casals-Pascual C	Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo.	Blood	2006	61
glycoproteins	16868999	7124	Dixon WG	Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.	Arthritis and rheumatism	2006	87
glycoproteins	16971520	7124	McCoy MK	Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.	The Journal of neuroscience 	2006	98
glycoproteins	17093155	7124	Weiss EP	Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial.	The American journal of clinical nutrition	2006	106
glycoproteins	17195186	7124	Hyrich KL	Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.	Arthritis and rheumatism	2007	67
glycoproteins	17202130	7124	Popa C	The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.	Journal of lipid research	2007	83
glycoproteins	17339326	7124	Hamik A	Kruppel-like factor 4 regulates endothelial inflammation.	The Journal of biological chemistry	2007	115
glycoproteins	17393394	7124	Curtis JR	Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.	Arthritis and rheumatism	2007	56
glycoproteins	17469100	7124	Wolfe F	The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.	Arthritis and rheumatism	2007	57
glycoproteins	17470824	7124	Sandborn WJ	Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.	Annals of internal medicine	2007	104
glycoproteins	17560496	7124	Chez MG	Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.	Pediatric neurology	2007	65
glycoproteins	17632266	7124	Ramos-Casals M	Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.	Medicine	2007	73
glycoproteins	17660390	7124	Rajesh M	CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.	American journal of physiology. Heart and circulatory physiology	2007	70
glycoproteins	17702576	7124	Zhu G	Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.	Current biology 	2007	70
glycoproteins	17763428	7124	Dixon WG	Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.	Arthritis and rheumatism	2007	69
glycoproteins	17916444	7124	Wong M	TNFalpha blockade in human diseases: mechanisms and future directions.	Clinical immunology	2008	64
glycoproteins	18036647	7124	Brightling C	Targeting TNF-alpha: a novel therapeutic approach for asthma.	The Journal of allergy and clinical immunology	2008	63
glycoproteins	18048652	7124	Vasudevan S	Switching from repression to activation: microRNAs can up-regulate translation.	Science	2007	784
glycoproteins	18161752	7124	Bradley JR	TNF-mediated inflammatory disease.	The Journal of pathology	2008	251
glycoproteins	18184433	7124	Tobinick EL	Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.	Journal of neuroinflammation	2008	53
glycoproteins	18438840	7124	Mitoma H	Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.	Arthritis and rheumatism	2008	51
glycoproteins	18485876	7124	Wang L	TNF-alpha induces two distinct caspase-8 activation pathways.	Cell	2008	297
glycoproteins	18492747	7124	Hivert MF	Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.	The Journal of clinical endocrinology and metabolism	2008	70
glycoproteins	18550004	7124	Peyrin-Biroulet L	Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.	Clinical gastroenterology and hepatology 	2008	76
glycoproteins	18560012	7124	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	76
glycoproteins	18566296	7124	Apovian CM	Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2008	90
glycoproteins	18613827	7124	Feldmann M	Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.	Immunological reviews	2008	59
glycoproteins	18625622	7124	Emery P	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.	Annals of the rheumatic diseases	2008	181
glycoproteins	18632147	7124	Ruperto N	Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.	Lancet	2008	62
glycoproteins	18709470	7124	Yang H	Mesothelioma epidemiology, carcinogenesis, and pathogenesis.	Current treatment options in oncology	2008	52
glycoproteins	18716298	7124	Lovell DJ	Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.	The New England journal of medicine	2008	71
glycoproteins	18848937	7124	Boetticher NC	A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.	Gastroenterology	2008	62
glycoproteins	19015206	7124	Fleischmann R	Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.	Annals of the rheumatic diseases	2009	64
glycoproteins	19019895	7124	Radstake TR	Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.	Annals of the rheumatic diseases	2009	68
glycoproteins	19117595	7124	Furst DE	The risk of infections with biologic therapies for rheumatoid arthritis.	Seminars in arthritis and rheumatism	2010	43
glycoproteins	19136369	7124	Wenzel SE	A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.	American journal of respiratory and critical care medicine	2009	68
glycoproteins	19168509	7124	Heymans S	Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.	European journal of heart failure	2009	53
glycoproteins	19210794	7124	Jones SE	Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.	BMC microbiology	2009	56
glycoproteins	19224750	7124	Strangfeld A	Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.	JAMA	2009	79
glycoproteins	19249397	7124	Rutgeerts P	Biological therapies for inflammatory bowel diseases.	Gastroenterology	2009	72
glycoproteins	19333944	7124	Kavanaugh A	Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.	Arthritis and rheumatism	2009	60
glycoproteins	19419979	7124	Aouizerat BE	Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue.	Biological research for nursing	2009	50
glycoproteins	19421244	7124	McKellar GE	Role for TNF in atherosclerosis? Lessons from autoimmune disease.	Nature reviews. Cardiology	2009	52
glycoproteins	19558997	7124	Siegel CA	Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.	Clinical gastroenterology and hepatology 	2009	66
glycoproteins	19560810	7124	Smolen JS	Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.	Lancet	2009	68
glycoproteins	19565495	7124	Tubach F	Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.	Arthritis and rheumatism	2009	66
glycoproteins	19652016	7124	Smith AM	Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.	The Journal of experimental medicine	2009	107
glycoproteins	19689289	7124	Esposito E	TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.	Current medicinal chemistry	2009	45
glycoproteins	19738171	7124	Holmes C	Systemic inflammation and disease progression in Alzheimer disease.	Neurology	2009	165
glycoproteins	19826084	7124	Wada Y	A wave of nascent transcription on activated human genes.	Proceedings of the National Academy of Sciences of the United States of America	2009	72
glycoproteins	19854715	7124	Dixon WG	Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).	Annals of the rheumatic diseases	2010	71
glycoproteins	20145610	7124	Afif W	Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease.	The American journal of gastroenterology	2010	70
glycoproteins	20173395	7124	Sfikakis PP	The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.	Current directions in autoimmunity	2010	53
glycoproteins	20862678	7124	Saevarsdottir S	Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.	Arthritis and rheumatism	2011	39
glycoproteins	20876255	7124	Libutti SK	Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.	Clinical cancer research 	2010	91
glycoproteins	20888436	7124	Kotlyar DS	A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.	Clinical gastroenterology and hepatology 	2011	46
glycoproteins	20957658	7124	Barnabe C	Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis.	Arthritis care and research	2011	44
glycoproteins	21045814	7124	D'Haens GR	The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?	The American journal of gastroenterology	2011	73
glycoproteins	21109516	7124	Greenberg JD	Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.	Annals of the rheumatic diseases	2011	49
glycoproteins	21133840	7124	Parameswaran N	Tumor necrosis factor-α signaling in macrophages.	Critical reviews in eukaryotic gene expression	2010	89
glycoproteins	21209123	7124	Reinisch W	Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.	Gut	2011	104
glycoproteins	21245297	7124	Hess A	Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	50
glycoproteins	21254282	7124	Askling J	Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.	Pharmacoepidemiology and drug safety	2011	41
glycoproteins	21330639	7124	Soliman MM	Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.	Annals of the rheumatic diseases	2011	35
glycoproteins	21366636	7124	Ben-Horin S	Review article: loss of response to anti-TNF treatments in Crohn's disease.	Alimentary pharmacology and therapeutics	2011	54
glycoproteins	21540200	7124	van der Heijde D	2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.	Annals of the rheumatic diseases	2011	55
glycoproteins	21569482	7124	Danchuk S	Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6.	Stem cell research and therapy	2011	54
glycoproteins	21571731	7124	Chatzidionysiou K	Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.	Annals of the rheumatic diseases	2011	37
glycoproteins	21693740	7124	Solomon DH	Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.	JAMA	2011	64
glycoproteins	21917936	7124	Yang X	Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina.	Investigative ophthalmology and visual science	2011	37
glycoproteins	21969554	7124	Rajaram MV	Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b.	Proceedings of the National Academy of Sciences of the United States of America	2011	69
glycoproteins	22056398	7124	Grijalva CG	Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.	JAMA	2011	56
glycoproteins	22272322	7124	Aaltonen KJ	Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.	PloS one	2012	43
glycoproteins	22505457	7124	Harre U	Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.	The Journal of clinical investigation	2012	97
glycoproteins	22684480	7124	Swan C	Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.	Gut	2013	35
glycoproteins	22884417	7124	Ganz PA	Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?	Brain, behavior, and immunity	2013	44
glycoproteins	22887987	7124	Teo GS	Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms.	Stem cells	2012	33
glycoproteins	22945416	7124	Raison CL	A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.	JAMA psychiatry	2013	174
glycoproteins	23064634	7124	Dar RD	Transcriptional burst frequency and burst size are equally modulated across the human genome.	Proceedings of the National Academy of Sciences of the United States of America	2012	73
glycoproteins	23095282	7124	Mäki-Petäjä KM	Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.	Circulation	2012	32
glycoproteins	23103767	7124	Papantonis A	TNFα signals through specialized factories where responsive coding and miRNA genes are transcribed.	The EMBO journal	2012	34
glycoproteins	23178294	7124	Vincent FB	Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective.	Annals of the rheumatic diseases	2013	33
glycoproteins	23223420	7124	Garcês S	The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis.	Annals of the rheumatic diseases	2013	30
glycoproteins	23267561	7124	Christy AL	Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.	Journal of autoimmunity	2013	28
glycoproteins	23345452	7124	Paulsen MT	Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
glycoproteins	23399692	7124	van Schouwenburg PA	Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis.	Nature reviews. Rheumatology	2013	35
glycoproteins	23425071	7124	Aggarwal BB	Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.	British journal of pharmacology	2013	36
glycoproteins	23649185	7124	Ford AC	Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.	The American journal of gastroenterology	2013	37
glycoproteins	23735746	7124	Sandborn WJ	Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.	Gastroenterology	2014	87
glycoproteins	23770005	7124	Sandborn WJ	Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.	Gastroenterology	2014	81
glycoproteins	23792214	7124	Ben-Horin S	Optimizing anti-TNF treatments in inflammatory bowel disease.	Autoimmunity reviews	2014	31
glycoproteins	23878167	7124	Steenholdt C	Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial.	Gut	2014	42
glycoproteins	23993863	7124	Bhat KPL	Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.	Cancer cell	2013	159
glycoproteins	24141950	7124	Jin F	A high-resolution map of the three-dimensional chromatin interactome in human cells.	Nature	2013	272
glycoproteins	24291654	7124	Listing J	Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab.	Annals of the rheumatic diseases	2015	21
glycoproteins	24382349	7124	Kagoya Y	Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.	The Journal of clinical investigation	2014	29
glycoproteins	24388027	7124	Leise MD	Drug-induced liver injury.	Mayo Clinic proceedings	2014	41
glycoproteins	24506179	7124	Stidham RW	Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis.	Alimentary pharmacology and therapeutics	2014	22
glycoproteins	24718959	7124	Callhoff J	Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.	Annals of the rheumatic diseases	2015	22
glycoproteins	24859203	7124	Sands BE	Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.	Gastroenterology	2014	38
glycoproteins	24946050	7124	Gupta SC	Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols.	Archives of biochemistry and biophysics	2014	27
glycoproteins	24968272	7124	Steyers CM 3rd	Endothelial dysfunction in chronic inflammatory diseases.	International journal of molecular sciences	2014	38
glycoproteins	25165721	7124	Ozkok A	Pathophysiology of cisplatin-induced acute kidney injury.	BioMed research international	2014	35
glycoproteins	25411043	7124	Monaco C	Anti-TNF therapy: past, present and future.	International immunology	2015	20
glycoproteins	25422582	7124	Tuttolomondo A	Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.	Drug design, development and therapy	2014	23
glycoproteins	25535390	7124	He X	Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
glycoproteins	25562322	7124	Reissfelder C	Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.	The Journal of clinical investigation	2015	23
glycoproteins	25825775	7124	Checco JW	Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.	Proceedings of the National Academy of Sciences of the United States of America	2015	17
glycoproteins	25897019	7124	Ben-Horin S	Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima.	Gut	2016	11
glycoproteins	25986361	7124	Kolho KL	Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.	The American journal of gastroenterology	2015	15
glycoproteins	26008591	7124	Brenner D	Regulation of tumour necrosis factor signalling: live or let die.	Nature reviews. Immunology	2015	66
glycoproteins	26187233	7124	Ravussin E	A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	37
glycoproteins	26282644	7124	Horvat TZ	Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.	Journal of clinical oncology 	2015	38
glycoproteins	26582965	7124	Michielan A	Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.	Mediators of inflammation	2015	22
glycoproteins	28264816	7124	Smolen JS	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.	Annals of the rheumatic diseases	2017	12
immune+or+immune+system	8015728	7124	Mogi M	Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.	Neuroscience letters	1994	133
immune+or+immune+system	8119492	7124	Rietschel ET	Bacterial endotoxin: molecular relationships of structure to activity and function.	FASEB journal 	1994	266
immune+or+immune+system	9358102	7124	Liu Z	Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.	Journal of acquired immune deficiency syndromes and human retrovirology 	1997	191
immune+or+immune+system	9725266	7124	Balcewicz-Sablinska MK	Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.	Journal of immunology	1998	106
immune+or+immune+system	10604883	7124	Ouchi N	Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.	Circulation	1999	304
immune+or+immune+system	11092892	7124	Kelso GF	Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties.	The Journal of biological chemistry	2001	175
immune+or+immune+system	11792859	7124	Angelini G	Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.	Proceedings of the National Academy of Sciences of the United States of America	2002	83
immune+or+immune+system	11828008	7124	Piccioli D	Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.	The Journal of experimental medicine	2002	146
immune+or+immune+system	11907116	7124	Belge KU	The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.	Journal of immunology	2002	167
immune+or+immune+system	12493553	7124	Panossian LA	Telomere shortening in T cells correlates with Alzheimer's disease status.	Neurobiology of aging	2003	94
immune+or+immune+system	12682019	7124	Jordan A	HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.	The EMBO journal	2003	271
immune+or+immune+system	12949498	7124	Aggarwal BB	Signalling pathways of the TNF superfamily: a double-edged sword.	Nature reviews. Immunology	2003	502
immune+or+immune+system	15044327	7124	Hagemann T	Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.	Carcinogenesis	2004	92
immune+or+immune+system	15122768	7124	Naveau S	A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.	Hepatology	2004	72
immune+or+immune+system	15208584	7124	Wright RJ	Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy.	The Journal of allergy and clinical immunology	2004	71
immune+or+immune+system	15383597	7124	Levy O	Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.	Journal of immunology	2004	99
immune+or+immune+system	15613320	7124	Yonezawa A	Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.	Journal of virology	2005	70
immune+or+immune+system	16481637	7124	Berry MA	Evidence of a role of tumor necrosis factor alpha in refractory asthma.	The New England journal of medicine	2006	150
immune+or+immune+system	17066036	7124	Kawane K	Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.	Nature	2006	100
immune+or+immune+system	17660390	7124	Rajesh M	CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.	American journal of physiology. Heart and circulatory physiology	2007	70
immune+or+immune+system	17702576	7124	Zhu G	Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.	Current biology 	2007	70
immune+or+immune+system	17916444	7124	Wong M	TNFalpha blockade in human diseases: mechanisms and future directions.	Clinical immunology	2008	64
immune+or+immune+system	18560012	7124	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	76
immune+or+immune+system	18566296	7124	Apovian CM	Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2008	90
immune+or+immune+system	18613827	7124	Feldmann M	Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.	Immunological reviews	2008	59
immune+or+immune+system	19210794	7124	Jones SE	Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.	BMC microbiology	2009	56
immune+or+immune+system	19249397	7124	Rutgeerts P	Biological therapies for inflammatory bowel diseases.	Gastroenterology	2009	72
immune+or+immune+system	19652016	7124	Smith AM	Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.	The Journal of experimental medicine	2009	107
immune+or+immune+system	19738171	7124	Holmes C	Systemic inflammation and disease progression in Alzheimer disease.	Neurology	2009	165
immune+or+immune+system	21128258	7124	Mease P	Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.	Arthritis and rheumatism	2011	39
immune+or+immune+system	21133840	7124	Parameswaran N	Tumor necrosis factor-α signaling in macrophages.	Critical reviews in eukaryotic gene expression	2010	89
immune+or+immune+system	21252670	7124	Danesh-Meyer HV	Neuroprotection in glaucoma: recent and future directions.	Current opinion in ophthalmology	2011	37
immune+or+immune+system	21366636	7124	Ben-Horin S	Review article: loss of response to anti-TNF treatments in Crohn's disease.	Alimentary pharmacology and therapeutics	2011	54
immune+or+immune+system	21569482	7124	Danchuk S	Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6.	Stem cell research and therapy	2011	54
immune+or+immune+system	21917936	7124	Yang X	Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina.	Investigative ophthalmology and visual science	2011	37
immune+or+immune+system	21969554	7124	Rajaram MV	Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b.	Proceedings of the National Academy of Sciences of the United States of America	2011	69
immune+or+immune+system	22505457	7124	Harre U	Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.	The Journal of clinical investigation	2012	97
immune+or+immune+system	22684480	7124	Swan C	Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.	Gut	2013	35
immune+or+immune+system	22760290	7124	Zhang J	Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.	JAMA	2012	37
immune+or+immune+system	22842618	7124	Neurath MF	Mucosal healing in inflammatory bowel diseases: a systematic review.	Gut	2012	90
immune+or+immune+system	22887987	7124	Teo GS	Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms.	Stem cells	2012	33
immune+or+immune+system	23097584	7124	Marais S	Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.	Clinical infectious diseases 	2013	34
immune+or+immune+system	23178294	7124	Vincent FB	Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective.	Annals of the rheumatic diseases	2013	33
immune+or+immune+system	23192911	7124	Listing J	The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.	Rheumatology	2013	32
immune+or+immune+system	23223420	7124	Garcês S	The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis.	Annals of the rheumatic diseases	2013	30
immune+or+immune+system	23267561	7124	Christy AL	Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.	Journal of autoimmunity	2013	28
immune+or+immune+system	24415859	7124	Pedersen J	Inflammatory pathways of importance for management of inflammatory bowel disease.	World journal of gastroenterology	2014	24
immune+or+immune+system	25125469	7124	Shoemark DK	The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease.	Journal of Alzheimer's disease 	2015	17
immune+or+immune+system	25417597	7124	Costello ME	Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis.	Arthritis and rheumatology	2015	23
immune+or+immune+system	25422582	7124	Tuttolomondo A	Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.	Drug design, development and therapy	2014	23
immune+or+immune+system	25535390	7124	He X	Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
immune+or+immune+system	25562322	7124	Reissfelder C	Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.	The Journal of clinical investigation	2015	23
immune+or+immune+system	26117714	7124	Probert L	TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.	Neuroscience	2015	32
immune+or+immune+system	26282644	7124	Horvat TZ	Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.	Journal of clinical oncology 	2015	38
infectious+or+infection	2762307	7124	Duh EJ	Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.	Proceedings of the National Academy of Sciences of the United States of America	1989	228
infectious+or+infection	7935762	7124	McGuire W	Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.	Nature	1994	149
infectious+or+infection	8198398	7124	Tracey KJ	Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.	Annual review of medicine	1994	148
infectious+or+infection	8637514	7124	Fisher CJ Jr	Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.	The New England journal of medicine	1996	158
infectious+or+infection	9725266	7124	Balcewicz-Sablinska MK	Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.	Journal of immunology	1998	106
infectious+or+infection	10228190	7124	Present DH	Infliximab for the treatment of fistulas in patients with Crohn's disease.	The New England journal of medicine	1999	233
infectious+or+infection	10839541	7124	Borovikova LV	Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.	Nature	2000	542
infectious+or+infection	11156641	7124	Wigg AJ	The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.	Gut	2001	123
infectious+or+infection	11596589	7124	Keane J	Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.	The New England journal of medicine	2001	504
infectious+or+infection	12682019	7124	Jordan A	HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.	The EMBO journal	2003	271
infectious+or+infection	12799470	7124	Borisy AA	Systematic discovery of multicomponent therapeutics.	Proceedings of the National Academy of Sciences of the United States of America	2003	140
infectious+or+infection	14719195	7124	Furst DE	Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).	The Journal of rheumatology	2003	78
infectious+or+infection	14988838	7124	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	127
infectious+or+infection	15127338	7124	Wallis RS	Granulomatous infectious diseases associated with tumor necrosis factor antagonists.	Clinical infectious diseases 	2004	122
infectious+or+infection	15383597	7124	Levy O	Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.	Journal of immunology	2004	99
infectious+or+infection	15489357	7124	Edwards JL	The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.	Clinical microbiology reviews	2004	83
infectious+or+infection	15613320	7124	Yonezawa A	Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.	Journal of virology	2005	70
infectious+or+infection	16022777	7124	Uiprasertkul M	Influenza A H5N1 replication sites in humans.	Emerging infectious diseases	2005	81
infectious+or+infection	16162882	7124	Genovese MC	Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.	The New England journal of medicine	2005	212
infectious+or+infection	16705109	7124	Bongartz T	Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.	JAMA	2006	366
infectious+or+infection	16868999	7124	Dixon WG	Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.	Arthritis and rheumatism	2006	87
infectious+or+infection	17202130	7124	Popa C	The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.	Journal of lipid research	2007	83
infectious+or+infection	17290043	7124	Rennard SI	The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2007	64
infectious+or+infection	17393394	7124	Curtis JR	Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.	Arthritis and rheumatism	2007	56
infectious+or+infection	17470824	7124	Sandborn WJ	Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.	Annals of internal medicine	2007	104
infectious+or+infection	17940980	7124	Warfield KL	Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.	The Journal of infectious diseases	2007	96
infectious+or+infection	18029267	7124	Gupta V	Intraocular tuberculosis--an update.	Survey of ophthalmology	2007	79
infectious+or+infection	18161752	7124	Bradley JR	TNF-mediated inflammatory disease.	The Journal of pathology	2008	251
infectious+or+infection	18550004	7124	Peyrin-Biroulet L	Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.	Clinical gastroenterology and hepatology 	2008	76
infectious+or+infection	18709470	7124	Yang H	Mesothelioma epidemiology, carcinogenesis, and pathogenesis.	Current treatment options in oncology	2008	52
infectious+or+infection	18848937	7124	Boetticher NC	A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.	Gastroenterology	2008	62
infectious+or+infection	19117595	7124	Furst DE	The risk of infections with biologic therapies for rheumatoid arthritis.	Seminars in arthritis and rheumatism	2010	43
infectious+or+infection	19136369	7124	Wenzel SE	A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.	American journal of respiratory and critical care medicine	2009	68
infectious+or+infection	19224750	7124	Strangfeld A	Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.	JAMA	2009	79
infectious+or+infection	19854715	7124	Dixon WG	Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).	Annals of the rheumatic diseases	2010	71
infectious+or+infection	20675706	7124	Galloway JB	Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.	Rheumatology	2011	73
infectious+or+infection	22056398	7124	Grijalva CG	Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.	JAMA	2011	56
infectious+or+infection	22684480	7124	Swan C	Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.	Gut	2013	35
infectious+or+infection	22760290	7124	Zhang J	Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.	JAMA	2012	37
infectious+or+infection	23097584	7124	Marais S	Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.	Clinical infectious diseases 	2013	34
infectious+or+infection	23192911	7124	Listing J	The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.	Rheumatology	2013	32
infectious+or+infection	23649185	7124	Ford AC	Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.	The American journal of gastroenterology	2013	37
infectious+or+infection	23735746	7124	Sandborn WJ	Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.	Gastroenterology	2014	87
infectious+or+infection	26008591	7124	Brenner D	Regulation of tumour necrosis factor signalling: live or let die.	Nature reviews. Immunology	2015	66
infectious+or+infection	28264816	7124	Smolen JS	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.	Annals of the rheumatic diseases	2017	12
rheumatic	12905464	7124	Gómez-Reino JJ	Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.	Arthritis and rheumatism	2003	128
rheumatic	15505111	7124	Newburger JW	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.	Circulation	2004	252
rheumatic	15574639	7124	Newburger JW	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.	Pediatrics	2004	185
rheumatic	16447241	7124	Wolfe F	Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.	Arthritis and rheumatism	2006	60
rheumatic	16705046	7124	Hyrich KL	Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.	Rheumatology	2006	103
rheumatic	17469100	7124	Wolfe F	The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.	Arthritis and rheumatism	2007	57
rheumatic	17632266	7124	Ramos-Casals M	Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.	Medicine	2007	73
rheumatic	18438853	7124	van der Heijde D	Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.	Arthritis and rheumatism	2008	76
rheumatic	19421244	7124	McKellar GE	Role for TNF in atherosclerosis? Lessons from autoimmune disease.	Nature reviews. Cardiology	2009	52
rheumatic	19703304	7124	van der Heijde D	Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.	Arthritis research and therapy	2009	55
rheumatic	22562972	7124	Burmester GR	Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.	Annals of the rheumatic diseases	2013	47
rheumatic	25169849	7124	Sedger LM	TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future.	Cytokine and growth factor reviews	2014	40
rheumatic	28264816	7124	Smolen JS	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.	Annals of the rheumatic diseases	2017	12
toxicology+or+toxic+or+toxin	8119492	7124	Rietschel ET	Bacterial endotoxin: molecular relationships of structure to activity and function.	FASEB journal 	1994	266
toxicology+or+toxic+or+toxin	8198398	7124	Tracey KJ	Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.	Annual review of medicine	1994	148
toxicology+or+toxic+or+toxin	8637514	7124	Fisher CJ Jr	Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.	The New England journal of medicine	1996	158
toxicology+or+toxic+or+toxin	9219699	7124	Moreland LW	Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.	The New England journal of medicine	1997	180
toxicology+or+toxic+or+toxin	10449104	7124	-	TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.	Neurology	1999	134
toxicology+or+toxic+or+toxin	10839541	7124	Borovikova LV	Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.	Nature	2000	542
toxicology+or+toxic+or+toxin	11792859	7124	Angelini G	Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.	Proceedings of the National Academy of Sciences of the United States of America	2002	83
toxicology+or+toxic+or+toxin	11907116	7124	Belge KU	The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.	Journal of immunology	2002	167
toxicology+or+toxic+or+toxin	15044327	7124	Hagemann T	Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.	Carcinogenesis	2004	92
toxicology+or+toxic+or+toxin	15383597	7124	Levy O	Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.	Journal of immunology	2004	99
toxicology+or+toxic+or+toxin	17660390	7124	Rajesh M	CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.	American journal of physiology. Heart and circulatory physiology	2007	70
toxicology+or+toxic+or+toxin	20876255	7124	Libutti SK	Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.	Clinical cancer research 	2010	91
toxicology+or+toxic+or+toxin	21245297	7124	Hess A	Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	50
toxicology+or+toxic+or+toxin	21569482	7124	Danchuk S	Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6.	Stem cell research and therapy	2011	54
toxicology+or+toxic+or+toxin	21969554	7124	Rajaram MV	Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b.	Proceedings of the National Academy of Sciences of the United States of America	2011	69
toxicology+or+toxic+or+toxin	22884417	7124	Ganz PA	Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?	Brain, behavior, and immunity	2013	44
toxicology+or+toxic+or+toxin	22955726	7124	Griep LM	BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function.	Biomedical microdevices	2013	49
